1
|
Sathya Priyadarshini G, Subramani R, Elakkiya S, Gopal S. Synthesis of novel luminescent cyclometallated platinum (IV) complexes with a quinoline Schiff bases ligand and their photophysical properties. INORG NANO-MET CHEM 2022. [DOI: 10.1080/24701556.2022.2068593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
| | - Ramesh Subramani
- Department of Food Processing Technology and Management, PSGR Krishnammal College for Women, Coimbatore, India
| | - S. Elakkiya
- Department of Chemistry, PSGR Krishnammal College for Women, Coimbatore, India
| | - Selvi Gopal
- Department of Chemistry, PSGR Krishnammal College for Women, Coimbatore, India
| |
Collapse
|
2
|
Schultz FA, Lord RL, Baik MH. Multifaceted examination of multielectron transfer reactions. Inorganica Chim Acta 2020. [DOI: 10.1016/j.ica.2020.119746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
3
|
Zhong Y, Jia C, Zhang X, Liao X, Yang B, Cong Y, Pu S, Gao C. Synthesis, characterization, and antitumor activity of novel tumor‐targeted platinum(IV) complexes. Appl Organomet Chem 2020. [DOI: 10.1002/aoc.5577] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Yunshuang Zhong
- Faculty of Life Science and TechnologyKunming University of Science and Technology Kunming 650500 China
| | - Chunyan Jia
- Faculty of Life Science and TechnologyKunming University of Science and Technology Kunming 650500 China
| | - Xinzhong Zhang
- Faculty of Life Science and TechnologyKunming University of Science and Technology Kunming 650500 China
| | - Xiali Liao
- Faculty of Life Science and TechnologyKunming University of Science and Technology Kunming 650500 China
| | - Bo Yang
- Faculty of Life Science and TechnologyKunming University of Science and Technology Kunming 650500 China
| | - Yanwei Cong
- Kunming Guiyan Pharmaceutical Co. Ltd Kunming Yunnan 650221 China
| | - Shaoping Pu
- Kunming Guiyan Pharmaceutical Co. Ltd Kunming Yunnan 650221 China
| | - Chuanzhu Gao
- Faculty of Life Science and TechnologyKunming University of Science and Technology Kunming 650500 China
| |
Collapse
|
4
|
Targeting drug delivery system for platinum(Ⅳ)-Based antitumor complexes. Eur J Med Chem 2020; 194:112229. [PMID: 32222677 DOI: 10.1016/j.ejmech.2020.112229] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2020] [Revised: 03/04/2020] [Accepted: 03/10/2020] [Indexed: 12/22/2022]
Abstract
Classical platinum(II) anticancer agents are widely-used chemotherapeutic drugs in the clinic against a range of cancers. However, severe systemic toxicity and drug resistance have become the main obstacles which limit their application and effectiveness. Because divalent cisplatin analogues are easily destroyed in vivo, their bioavailability is low and no selective to tumor tissues. The platinum(IV) prodrugs are attractive compounds for cancer treatment because they have great advantages, e.g., higher stability in biological media, aqueous solubility and no cross-resistance with cisplatin, which may become the next generation of platinum anticancer drugs. In addition, platinum(IV) drugs could be taken orally, which could be more acceptable to cancer patients, breaking the current situation that platinum(II) drugs can only be given by injection. The coupling of platinum(IV) complexes with tumor targeting groups avoids the disadvantages such as instability in blood, irreversible binding to plasma proteins, rapid renal clearance, and non-specific distribution in normal tissues. Because of the above advantages, the combination of platinum complexes and tumor targeting groups has become the hottest field in the research and development of new platinum drugs. These approaches can be roughly categorized into two groups: active and passive targeted strategies. This review concentrates on various targeting and delivery strategies for platinum(IV) complexes to improve the efficacy and reduce the side effects of platinum-based anticancer drugs. We have made a summary of the related articles on platinum(IV) targeted delivery in recent years. We believe the results of the studies described in this review will provide new ideas and strategies for the development of platinum drugs.
Collapse
|
5
|
Corinti D, Crestoni ME, Fornarini S, Ponte F, Russo N, Sicilia E, Gabano E, Osella D. Elusive Intermediates in the Breakdown Reactivity Patterns of Prodrug Platinum(IV) Complexes. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY 2019; 30:1881-1894. [PMID: 30980381 DOI: 10.1007/s13361-019-02186-7] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/01/2019] [Revised: 03/01/2019] [Accepted: 03/05/2019] [Indexed: 06/09/2023]
Abstract
Kinetically inert platinum(IV) complexes are receiving growing attention as promising candidates in the effort to develop safe and valid alternatives to classical square-planar Pt(II) complexes currently used in antineoplastic therapy. Their antiproliferative activity requires intracellular Pt(IV)-Pt(II) reduction (activation by reduction). In the present work, a set of five Pt(IV) complexes has been assayed using mass spectrometry-based techniques, i.e., collision-induced dissociation (CID), and IR multiple photon dissociation (IRMPD) spectroscopy, together with ab initio theoretical investigations. Breakdown and reduction mechanisms are observed that lead to Pt(II) species. Evidence is found for typically transient Pt(III) intermediates along the dissociation paths of isolated, negatively charged (electron-rich) Pt(IV) prodrug complexes.
Collapse
Affiliation(s)
- Davide Corinti
- Dipartimento di Chimica e Tecnologie del Farmaco, Università di Roma "La Sapienza", P.le A. Moro 5, 00185, Rome, Italy
| | - Maria Elisa Crestoni
- Dipartimento di Chimica e Tecnologie del Farmaco, Università di Roma "La Sapienza", P.le A. Moro 5, 00185, Rome, Italy
| | - Simonetta Fornarini
- Dipartimento di Chimica e Tecnologie del Farmaco, Università di Roma "La Sapienza", P.le A. Moro 5, 00185, Rome, Italy.
| | - Fortuna Ponte
- Department of Chemistry and Chemical Technologies, Università della Calabria, Ponte P. Bucci Cubo 14c, 87036, Arcavacata di Rende, Italy
| | - Nino Russo
- Department of Chemistry and Chemical Technologies, Università della Calabria, Ponte P. Bucci Cubo 14c, 87036, Arcavacata di Rende, Italy
| | - Emilia Sicilia
- Department of Chemistry and Chemical Technologies, Università della Calabria, Ponte P. Bucci Cubo 14c, 87036, Arcavacata di Rende, Italy.
| | - Elisabetta Gabano
- Dipartimento di Scienze e Innovazione Tecnologica, Università del Piemonte Orientale, Viale T. Michel 11, 15121, Alessandria, Italy
| | - Domenico Osella
- Dipartimento di Scienze e Innovazione Tecnologica, Università del Piemonte Orientale, Viale T. Michel 11, 15121, Alessandria, Italy.
| |
Collapse
|
6
|
Wang Q, Li G, Liu Z, Tan X, Ding Z, Ma J, Li L, Li D, Han J, Wang B. Naphthalimide Platinum(IV) Compounds as Antitumor Agents with Dual DNA Damage Mechanism to Overcome Cisplatin Resistance. Eur J Inorg Chem 2018. [DOI: 10.1002/ejic.201800799] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- Qingpeng Wang
- Institute of Biopharmaceutical Research; Liaocheng University; 252059 Liaocheng P.R. China
| | - Guoshuai Li
- Institute of Biopharmaceutical Research; Liaocheng University; 252059 Liaocheng P.R. China
| | - Zhifang Liu
- Institute of Biopharmaceutical Research; Liaocheng University; 252059 Liaocheng P.R. China
| | - Xiaoxiao Tan
- Institute of Biopharmaceutical Research; Liaocheng University; 252059 Liaocheng P.R. China
| | - Zhuang Ding
- Institute of Biopharmaceutical Research; Liaocheng University; 252059 Liaocheng P.R. China
| | - Jing Ma
- Institute of Chemical Biology; College of Pharmacy; Henan University; 475004 Kaifeng P.R. China
| | - Lanjie Li
- Institute of Biopharmaceutical Research; Liaocheng University; 252059 Liaocheng P.R. China
| | - Dacheng Li
- Institute of Biopharmaceutical Research; Liaocheng University; 252059 Liaocheng P.R. China
| | - Jun Han
- Institute of Biopharmaceutical Research; Liaocheng University; 252059 Liaocheng P.R. China
| | - Bingquan Wang
- Institute of Biopharmaceutical Research; Liaocheng University; 252059 Liaocheng P.R. China
| |
Collapse
|
7
|
Wang Q, Tan X, Liu Z, Li G, Zhang R, Wei J, Wang S, Li D, Wang B, Han J. Design and synthesis of a new series of low toxic naphthalimide platinum(IV) antitumor complexes with dual DNA damage mechanism. Eur J Pharm Sci 2018; 124:127-136. [PMID: 30153524 DOI: 10.1016/j.ejps.2018.08.032] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2018] [Revised: 08/08/2018] [Accepted: 08/23/2018] [Indexed: 01/31/2023]
Abstract
Naphthalimide platinum(IV) antitumor complexes with potential dual DNA damage mechanism were designed, synthesized and evaluated for antitumor activities. The incorporation of DNA targeted naphthalimide group to the platinum(IV) system exerts much positive impacts on their antitumor efficacy. The mechanism research reveals that the title compounds could interact with dsDNA in platinum(IV) form via the naphthalimide group and cause DNA lesion. The further reduction would release platinum(II) complexes and naphthalimide acids which would induce remarkable secondary damage to DNA. Furthermore, the naphthalimide platinum(IV) compounds could combine with human serum albumin via electrostatic force, which are favourable for their storage and transport in blood. Moreover, the title compounds exhibit higher accumulation in tumor cells, and exert lower toxic and higher safe properties than oxaliplatin in vivo.
Collapse
Affiliation(s)
- Qingpeng Wang
- Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China.
| | - Xiaoxiao Tan
- Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China
| | - Zhifang Liu
- Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China
| | - Guoshuai Li
- Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China
| | - Ruiyan Zhang
- Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China
| | - Jinjian Wei
- College of Chemistry, Chemical Engineering and Materials Science, Shandong Normal University, Jinan 250014, PR China
| | - Shiben Wang
- College of Pharmacy, Liaocheng University, Liaocheng 252059, PR China
| | - Dacheng Li
- Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China.
| | - Bingquan Wang
- Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China
| | - Jun Han
- Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China
| |
Collapse
|
8
|
Šebesta F, Burda JV. Interactions of Ascorbic Acid with Satraplatin and its trans
Analog JM576: DFT Computational Study. Eur J Inorg Chem 2018. [DOI: 10.1002/ejic.201701334] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
- Filip Šebesta
- Department of Chemical Physics and Optics; Faculty of Mathematics and Physics; Charles University; Ke Karlovu 3 121 16 Prague 2 Czech Republic
| | - Jaroslav V. Burda
- Department of Chemical Physics and Optics; Faculty of Mathematics and Physics; Charles University; Ke Karlovu 3 121 16 Prague 2 Czech Republic
| |
Collapse
|
9
|
Šebesta F, Baxová K, Burda JV. Redox Potentials for Tetraplatin, Satraplatin, Its Derivatives, and Ascorbic Acid: A Computational Study. Inorg Chem 2018; 57:951-962. [DOI: 10.1021/acs.inorgchem.7b01894] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Filip Šebesta
- Department of Chemical Physics and Optics,
Faculty of Mathematics and Physics, Charles University, Ke Karlovu
3, 121 16 Prague
2, Czech Republic
| | - Katarína Baxová
- Department of Chemical Physics and Optics,
Faculty of Mathematics and Physics, Charles University, Ke Karlovu
3, 121 16 Prague
2, Czech Republic
| | - Jaroslav V. Burda
- Department of Chemical Physics and Optics,
Faculty of Mathematics and Physics, Charles University, Ke Karlovu
3, 121 16 Prague
2, Czech Republic
| |
Collapse
|